Teva Announces New Org Structure, Leadership Changes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva | Partnership | Direct Relief
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
Dana Lev - Finance Director, Global Treasury - Teva Pharmaceuticals | LinkedIn
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Teva Announces Appointment of New Chief Financial Officer | Business Wire
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more